GENMAB AS SP.ADR/1/10DK 1 Capital Reinvestment Ratio
GENMAB AS SP.ADR/1/10DK 1 capital reinvestment ratio. GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (€301.00 Million) in capital expenditures (€13.00 Million). Check GENMAB AS SP.ADR/1/10DK 1 (GE91) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Capital reinvestment ratio of GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025. This chart tracks GENMAB AS SP.ADR/1/10DK 1's Capital Reinvestment Ratio across 5 annual periods. Also explore GENMAB AS SP.ADR/1/10DK 1 (GE91) net asset momentum to track the company's year-over-year net asset growth rate.
GENMAB AS SP.ADR/1/10DK 1 Capital Reinvestment Ratio by Year (2021–2025)
GENMAB AS SP.ADR/1/10DK 1 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see GENMAB AS SP.ADR/1/10DK 1 cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | €1.19 Billion | €55.00 Million | ▲ +18.5% |
| 2024 | 0.04x | €1.08 Billion | €42.41 Million | ▼ -23.2% |
| 2023 | 0.05x | €1.10 Billion | €55.83 Million | ▼ -37.1% |
| 2022 | 0.08x | €563.05 Million | €45.63 Million | ▼ -28.4% |
| 2021 | 0.11x | €339.18 Million | €38.36 Million | — |